Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Ikapharmindo Putramas TbkISX:IKPM -0.54% Buyback Yield % is 0.00 as of Jul. 28, 2026. The stock has 1 warning sign investors should review. Among 276 Healthcare Providers & Services companies, PT Ikapharmindo Putramas Tbk ranks worse than 362318.48% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Pharmaceutical Retailers subindustry, PT Ikapharmindo Putramas Tbk's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Ikapharmindo Putramas Tbk Buyback Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Ikapharmindo Putramas Tbk's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where PT Ikapharmindo Putramas Tbk's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Ikapharmindo Putramas Tbk (ISX:IKPM) has a Buyback Yield % of 0.00 as of Jul. 28, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on PT Ikapharmindo Putramas Tbk and its competitors. According to the industry distribution chart, PT Ikapharmindo Putramas Tbk ranks #999999 out of 276 companies in the Healthcare Providers & Services industry.
Is PT Ikapharmindo Putramas Tbk's Buyback Yield % too high?
PT Ikapharmindo Putramas Tbk's current Buyback Yield % is 0.00. Based on the distribution chart, PT Ikapharmindo Putramas Tbk ranks #999999 out of 276 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does PT Ikapharmindo Putramas Tbk's Buyback Yield % compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, PT Ikapharmindo Putramas Tbk ranks #999999 out of 276 companies for Buyback Yield %. This places PT Ikapharmindo Putramas Tbk in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Healthcare Providers & Services company?
A good Buyback Yield % depends on the Healthcare Providers & Services industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on PT Ikapharmindo Putramas Tbk and its competitors. PT Ikapharmindo Putramas Tbk's current Buyback Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Ikapharmindo Putramas Tbk stock overvalued right now?
PT Ikapharmindo Putramas Tbk (ISX:IKPM) has a current Buyback Yield % of 0.00. The current Buyback Yield % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For PT Ikapharmindo Putramas Tbk (ISX:IKPM), the current Buyback Yield % is 0.00 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Ikapharmindo Putramas Tbk is a factory and marketer of Pharmaceutical Products and Consumer Health Products located in Jakarta, Indonesia. Company has three reportable segments including non-pharma, pharma and contract manufacturing deriving key revenue from the Non- Pharma segment. It focuses on providing good quality and a diverse portfolio to the Indonesian market, with trusted brands in the Pharmaceutical Product Categories of Prescription Medicines, OTC, Nutraceuticals, Professional Hair Care Products and Baby Products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:IKPM has been successfully added to your 
